Rankings
▼
Calendar
FLGT Q1 2024 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$458M
Q1 2024 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$64M
-2.5% YoY
Gross Profit
$22M
34.3% margin
Operating Income
-$22M
-33.8% margin
Net Income
-$13M
-20.9% margin
EPS (Diluted)
$-0.45
QoQ Revenue Growth
-8.5%
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
$3M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$103M
Stockholders' Equity
$1.1B
Cash & Equivalents
$55M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64M
$66M
-2.5%
Gross Profit
$22M
$19M
+17.5%
Operating Income
-$22M
-$25M
+12.2%
Net Income
-$13M
-$15M
+12.2%
Revenue Segments
Laboratory Services
$64M
100%
Geographic Segments
UNITED STATES
$58M
90%
CHINA
$4M
6%
Other Countries
$3M
4%
← FY 2024
All Quarters
Q2 2024 →